In this study, we identified circMDK as an oncogenic circRNA in HCC by RNA sequencing (RNA-seq), and validated ATG16L1 as its target gene by sponging miR-346 and miR-874-3p, resulting in activation of PI3K/AKT/mTOR pathway. This evidence concerns the gene AKT1 and hepatocellular carcinoma.